HomeCompareAPELF vs JNJ

APELF vs JNJ: Dividend Comparison 2026

APELF yields 4.02% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $7.5K in total portfolio value· pulled ahead in Year 8
10 years
APELF
APELF
● Live price
4.02%
Share price
$10.00
Annual div
$0.40
5Y div CAGR
-12.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.0K
Annual income
$125.77
Full APELF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — APELF vs JNJ

📍 JNJ pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAPELFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, APELF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
APELF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

APELF
Annual income on $10K today (after 15% tax)
$341.67/yr
After 10yr DRIP, annual income (after tax)
$106.90/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, JNJ beats the other by $3,930.49/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of APELF + JNJ for your $10,000?

APELF: 50%JNJ: 50%
100% JNJ50/50100% APELF
Portfolio after 10yr
$26.7K
Annual income
$2,437.83/yr
Blended yield
9.12%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

APELF
No analyst data
Altman Z
2.9
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

APELF buys
0
JNJ buys
0
No recent congressional trades found for APELF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAPELFJNJ
Forward yield4.02%2.14%
Annual dividend / share$0.40$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-12.3%28%
Portfolio after 10y$23.0K$30.5K
Annual income after 10y$125.77$4,749.88
Total dividends collected$2.3K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: APELF vs JNJ ($10,000, DRIP)

YearAPELF PortfolioAPELF Income/yrJNJ PortfolioJNJ Income/yrGap
1$11,053$352.53$10,594$274.49+$459.00APELF
2$12,146$319.35$11,294$360.69+$852.00APELF
3$13,283$287.64$12,133$476.91+$1.1KAPELF
4$14,471$257.84$13,156$635.42+$1.3KAPELF
5$15,714$230.23$14,432$854.61+$1.3KAPELF
6$17,019$204.91$16,056$1,162.76+$963.00APELF
7$18,392$181.90$18,175$1,604.53+$217.00APELF
8← crossover$19,841$161.12$21,009$2,252.68$1.2KJNJ
9$21,372$142.46$24,911$3,229.73$3.5KJNJ
10$22,994$125.77$30,458$4,749.88$7.5KJNJ

APELF vs JNJ: Complete Analysis 2026

APELFStock

Alps Alpine Co., Ltd. manufactures and sells electronic components in Japan and internationally. It operates through three segments: Electronic Components, Automotive Infotainment, and Logistics. The Electronic Components segment develops, manufactures, and markets electronic components. The Automotive Infotainment segment develops, manufactures, and markets audio, information, and communication equipment. The Logistics segment offers transportation, storage, and forwarding services. Its products for the consumer, energy, healthcare, industry, and IoT markets include TACT switches, multi-directional operating devices, toroidal coils, aspherical glass lens, PC board mount current sensors, slide potentiometers, encoders, actuators, and reactors, as well as pressure, geomagnetic, force, and humidity sensors; sensor network, environmental sensor, and power conversion modules; compact printers; and remote monitoring system for logistics, worker condition monitoring systems, obstacle detection unit for sidewalks, and ground wire automated tracking and inspection drone systems. The company's products for the automotive market comprises TACT and detector switches, wireless LAN/Bluetooth combination modules, V2X and LTE modules, encoders, and engine start switches; stand position, EGR valve, and current sensors; power windows, electronic parking systems, intelligent control panels, electric shifters, steering wheel modules, sound system speakers, vehicle-approaching alert systems, amplifier for in-vehicle sound systems, displays, and camera/drive recorders; and car navigation systems, premium sound speakers, customized car products, rental car provider solutions, rear seat monitors, and camera systems. It also provides systems development, office, and financing and leasing services. The company was formerly known as Alps Electric Co., Ltd. and changed its name to Alps Alpine Co., Ltd. in January 2019. The company was incorporated in 1948 and is headquartered in Tokyo, Japan.

Full APELF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this APELF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

APELF vs SCHDAPELF vs JEPIAPELF vs OAPELF vs KOAPELF vs MAINAPELF vs ABBVAPELF vs MRKAPELF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.